LNSR

LENSAR Inc

Healthcare
Medical - Devices
$93M market cap

Forecast run · Sep 14, 2026Upside rank 1022 of 3,136

Model Signal

ForecastQ Daily Probabilities

44.4%

44.8%

23.8%

Analyst Consensus

Recommendation2.33/5 Buy

Last price$7.60

Price target$11.50

Implied move+51.3%

Analysts3

ForecastQ Portfolios

LNSR is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.